Gilead Sciences | GILD - Дебиторская задолженность

Биржевая цена
130.84
Изменение за день
2.00 1.55%
Ежемесячно
-6.12%
Ежегодный
26.72%
Q2 прогноз
127.61




Дебиторская задолженность Изменить Дата
AbbVie USD 12.59B 180M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.52B 91M 2025-12
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 20.16B 697.8M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Incyte USD 1.05B 27.09M 2026-03
J&J USD 21.33B 3.72B 2025-12
Merck USD 11.78B 345M 2025-12
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
United Therapeutics USD 350.2M 52.5M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12